Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand

Prevalence of GERD in Patients With upperGITsymptoms in Thailand

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00999063

Acronym

GerdQ

Enrollment

4108

Registered

2009-10-21

Start date

2009-12-31

Completion date

2011-02-28

Last updated

2011-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper GIT Symptoms

Keywords

GerdQ

Brief summary

This is a prospective , epidemiological, multi-centre, phase IV study, approximately 5,000 patients who suffer with upper gastrointestinal tract symptoms. Each patient will be assessed for GERD with GerdQ Thai Version.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Provision of informed consent prior to any study specific procedures * Female or male aged at least 18 years * Patient must be having symptoms suggestive of upper gastrointestinal tract symptoms such as heart burn/ regurgitation

Exclusion criteria

* Involvement in the planning and /or conduct of the study (applies to both AstraZeneca staff and /or staff at study site * Participation in a clinical study(excluding non-interventional study or registry) during the last 3 months

Design outcomes

Primary

Measure	Time frame
Prevalence of gastroesophageal reflux disease (GERD) in patients presented with upper gastrointestinal tract symptoms	—

Secondary

Measure	Time frame
Response to various treatments for patients who have been diagnosed of GERD	—

Countries

Thailand

Outcome results